LeConte Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Buy
5,073
+207
+4% +$48.2K 0.7% 30
2026
Q1
$1.19M Buy
4,866
+104
+2% +$24.2K 0.77% 28
2025
Q4
$986K Buy
4,762
+355
+8% +$70.2K 0.64% 27
2025
Q3
$817K Buy
4,407
+852
+24% +$146K 0.55% 29
2025
Q2
$543K Buy
3,555
+737
+26% +$113K 0.37% 39
2025
Q1
$467K Buy
+2,818
New +$441K 0.3% 30

Other funds holding JNJ

LeConte Wealth Management's JNJ Position: Q2 2026 in Review

LeConte Wealth Management increased its Johnson & Johnson (JNJ) stake by 4.3% in Q2 2026, buying an estimated $48.2K and bringing the position to 5,073 shares worth $1.29M. The position accounts for 0.7% of the portfolio, ranked #30.

LeConte Wealth Management first reported a position in JNJ in Q1 2025 and has held it in 6 quarters since. 4,683 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • LeConte Wealth Management held 5,073 shares of Johnson & Johnson worth $1.29M as of Q2 2026.
  • LeConte Wealth Management bought 207 Johnson & Johnson shares in Q2 2026, an estimated $48.2K.
  • Johnson & Johnson made up 0.7% of LeConte Wealth Management's portfolio in Q2 2026, its #30 holding.
  • LeConte Wealth Management first reported a position in Johnson & Johnson in Q1 2025 and has held it in 6 quarters since.
  • 4,683 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on LeConte Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.